More Handling of Changes to Medical Device Products for approved Combination Products
More Comprehensive Document about the Handling of OOE and OOT Results
More Deficiencies in Complaint and Recall Handling cause Warning Letter
More The Role of Visual Inspection in the Release of Parenterals
More FDA criticises missing Step 3 in the Process Validation Cycle
More Frequently asked: What does the Exposure Time of Disinfectants mean?
More ECA Visual Inspection Group Chairman appointed to EDQM Expert Group
More Qualification of Development Tools for Medical Devices - Guidance for Industry
More Guideline for Medicinal Products containing genetically modified Cells - EMA plans Revision
More FDA Information about Human Cell and Tissue (HCT/P) related Inspections
More EMA - New guide for healthcare professionals on biosimilar medicines
More FDA Warning Letter relating to the Use of an alternative microbiological Method
More Important Questions and Answers concerning the Audit Trail Review
More Warning Letter to Indian API Manufacturer: Equipment Deficiencies